Search
Fenvalerate
go.drugbank.com/drugs/DB18391ExperimentalCategories: Cytochrome P-450 CYP2D6 Inhibitors, Cytochrome P-450 CYP3A InhibitorsBefotertinib
go.drugbank.com/drugs/DB18844InvestigationalBefotertinib is under investigation in clinical trial NCT05007938 (Befotertinib and Icotinib in Treatment-naive Patients With Advanced Egfr-mutant Lung Cancer).
Categories: P-glycoprotein inhibitorsAvenciguat
go.drugbank.com/drugs/DB18882InvestigationalAvenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (N...
Categories: P-glycoprotein substratesEpaminurad
go.drugbank.com/drugs/DB18973InvestigationalEpaminurad is under investigation in clinical trial NCT05815901 (A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients).
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 SubstratesBersacapavir
go.drugbank.com/drugs/DB19035InvestigationalBersacapavir is under investigation in clinical trial NCT03365947 (Study of ARO-HBV in Normal Adult Volunteers and Patients With Hepatitis B Virus (HBV)).
Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 Substratesp-Boronophenylalanine
go.drugbank.com/drugs/DB19158Investigationalp-Boronophenylalanine is under investigation in clinical trial NCT00039572 (Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain).
Synonyms: L-p-boronophenylalanineHuman placenta hydrolysate
go.drugbank.com/drugs/DB19297InvestigationalCategories: Cytochrome P-450 CYP2E1 Inhibitors, Cytochrome P-450 Enzyme InhibitorsFilapixant
go.drugbank.com/drugs/DB21467ExperimentalFilapixant is a small molecule drug. The usage of the INN stem '-pixant' in the name indicates that Filapixant is a purinoreceptor (P2X) antagonist. Filapixant has a monoisotopic molecular weight of 521.17 Da.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesAzamulin
go.drugbank.com/drugs/DB20304ExperimentalAzamulin is a small molecule drug. Azamulin has a monoisotopic molecular weight of 478.26 Da.
Categories: Cytochrome P-450 CYP3A Inhibitors, Cytochrome P-450 SubstratesBurapitant
go.drugbank.com/drugs/DB20607ExperimentalThe usage of the INN stem '-pitant' in the name indicates that Burapitant is a neurokinin NK1 (substance P) receptor antagonist. Burapitant has a monoisotopic molecular weight of 681.2 Da.